Table 3.
Sub-analysis of each tendency of regression model for prolonged delirium/coma days
| Multivariate model 3 OR (95% CI) a | VIF | Multivariate model 4 OR (95% CI)a | VIF | |
|---|---|---|---|---|
| EuroSCOREII | 1.1 (0.9–1.3) | 1.3 | 1.1 (0.9–1.3) | 1.2 |
| MMSE | 0.9 (0.7–1.1) | 1.0 | 0.9 (0.7–1.3) | 1.1 |
| Negative Affectivity (NA) | 1.09 (1.03–1.15)* | 1.0 | ||
| Social Inhibition (SI) | 1.05 (1.0–1.1) * | 1.0 | ||
| Depressive symptomsb | 1.1 (1.0–1.3)* | 1.1 | 1.1 (1.0–1.3) * | 1.1 |
| Aortic clamping time | 0.9 (0.9–1.0) | 1.0 | 0.9 (0.9–1.0) | 1.0 |
| mSOFAc | 1.7 (1.3–2.2)* | 1.6 | 1.6 (1.2–2.1)* | 1.6 |
| Benzodiazepined | 9.9 (2.4–40.2)* | 1.0 | 9.8 (2.3–40.9)* | 1.0 |
| Propofold | 1.1(1.0–1.2)* | 1.8 | 1.1(1.0–1.2) * | 1.8 |
| Dexmedetomidinee | 1.1(0.9–1.2) | 1.7 | 1.1(0.9–1.3) | 1.7 |
a: P values obtained from Ordered Logistic Regression *P value<0.05
b: measured by Hospital Anxiety and Depression Scale (HADS)
c: Exclude GCS, used average of 7 days
d: Used average of 7 days. mg/day/kg
e: Used average of 7 days. μg/day/kg
MMSE mini-mental state examination, EuroSCOREII European System for Cardiac Operative Risk Evaluation II, mSOFA modified Sequential Organ Failure Assessment